Vaccinating Italian infants with a new multicomponent vaccine (Bexsero®) against meningococcal B disease: A cost-effectiveness analysis

Roberto GaspariniDepartment of Health Sciences, University of Genoa, Genoa, Italy

Paolo LandaDepartment of Economics, University of Genoa, Genoa, Italy;University of Exeter, Medical School, Exeter, UK

Daniela AmiciziaDepartment of Health Sciences, University of Genoa, Genoa, Italy

Giancarlo IcardiDepartment of Health Sciences, University of Genoa, Genoa, Italy

Walter RicciardiInstitute of Hygiene and Public Health, Catholic University of Sacred Heart, Rome, Italy

Chiara de WaureInstitute of Hygiene and Public Health, Catholic University of Sacred Heart, Rome, Italy

Elena TanfaniDepartment of Economics, University of Genoa, Genoa, Italy

Paolo BonanniDepartment of Health Sciences, University of Florence, Florence, Italy

Carlo LucioniWichtig International, Milan, Italy

Angela TestiDepartment of Economics, University of Genoa, Genoa, Italy

Donatella PanattoDepartment of Health Sciences, University of Genoa, Genoa, ItalyCorrespondence[email protected]

Your download is now in progress and you may close this window